Handelsavisen
prelaunch
AI
AIFF.O NASDAQ IT Services & Consulting

Firefly Neuroscience Inc

$1,29
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
26,0M USD
P/E
EV / Rev
Div yield
Op margin
-894,0 %
ROE
-260,3 %
Net margin
-1 741,0 %
Debt / equity
0,00
Beta
52w range
Volume
2
Day range
Prev close
$1,69
Open
Next earnings
2026-07-28
Ex-dividend
TR 1Y
About

Firefly Neuroscience Inc is a technology company focused on IT services and consulting, primarily operating in the health care technology sector.

Business. Firefly Neuroscience Inc (AIFF.O) is a technology company operating within the IT Services & Consulting industry, primarily generating service-based revenue. The firm is headquartered in the United States and is listed on the OTC market under the ticker AIFF.O. Specific details regarding operating segments and geographic revenue mix are not disclosed in the available data.

Classification92 %
SectorTechnology
Business sectorSoftware & IT Services
IndustryIT Services & Consulting
ActivityIT Services
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ2 2026 earnings (expected)2026-07-28 · estimated
See all catalysts →

At a glance

Score
28
composite score
Valuation
valuation pending
Analysts
not yet wired
Ownership
UBS Financial Services, Inc.
largest disclosed fund holder
Profitability
-260,3 %
return on equity
Quality
56
quality score (0-100)

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning AIFF.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,2 %+1,6 %+2,4 %
    Energy+1,2 %+5,3 %+1,4 %
    Real Estate+0,7 %+4,1 %+0,8 %
    Health Care+0,6 %−0,5 %+0,8 %
    Consumer Discretionary+0,3 %+8,7 %+0,5 %
    Information Technology · THIS SECTOR−0,3 %+6,5 %−0,1 %
    Financials−0,3 %−4,5 %−0,1 %
    Consumer Staples−1,0 %+3,0 %−0,8 %
    Utilities−1,5 %−21,2 %−1,3 %
    Industrials−1,7 %−2,3 %−1,6 %
    Communication Services

    Developing storylines

    No tracked sagas currently linked to AIFF.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-07-07 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ2 2026 earnings (expected)2026-07-28 · estimated
    • Macro
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
    • Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
    • Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
    • Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Composite score28 / 100
    Composite score 0-100 · Data quality 0,56
    Data quality0,56 / 1.00

    Synthesis

    Business

    Firefly Neuroscience Inc (AIFF.O) is a technology company operating within the IT Services & Consulting industry, primarily generating service-based revenue. The firm is headquartered in the United States and is listed on the OTC market under the ticker AIFF.O. Specific details regarding operating segments and geographic revenue mix are not disclosed in the available data.

    Classification92 %
    SectorTechnology
    Business sectorSoftware & IT Services
    IndustryIT Services & Consulting
    ActivityIT Services
    AI synthesis
    GENERATED

    Firefly Neuroscience Inc has a market capitalization of $38.84 million and a price-to-book ratio of 5.09, indicating a premium valuation relative to its book value. The company's liquidity position is characterized by a current ratio of 1.43, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company has no long-term debt and a debt-to-equity ratio of 0.0, indicating a conservative capital structure.

    The company's profitability metrics are concerning, with a return on equity of -2.60 and a return on assets of -1.8977, both significantly below industry norms. Operating income and net income are negative at -$10.21 million and -$19.88 million, respectively, indicating ongoing operational losses. Gross profit of $645,000 is modest compared to the company's revenue of $1.14 million, suggesting high cost structures or low-margin operations.

    Firefly Neuroscience Inc's revenue is concentrated in a single business segment, with no disclosed geographic diversification. The company's financial snapshot does not provide segment-specific revenue data, but the absence of geographic breakdown suggests potential concentration risk. The company's operating cash flow is negative at -$8.19 million, and free cash flow is -$19.84 million, indicating a significant cash outflow from operations.

    The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the outlook. The negative operating and free cash flows suggest the company is not generating sufficient cash to sustain operations without external financing. The company's capital expenditure of -$128,000 is minimal, indicating limited investment in long-term assets.

    Risk factors for Firefly Neuroscience Inc include low liquidity and the potential for dilution, although no immediate filing-based liquidity or dilution flags were detected. The company's negative net income and operating income suggest financial instability, and the absence of long-term debt may indicate a lack of strategic leverage. The company's valuation metrics, such as the high price-to-book ratio, suggest investor optimism despite poor financial performance.

    Recent events and filings do not indicate any significant changes in the company's financial or operational status. The company's financial snapshot does not provide specific details on recent events, but the absence of immediate liquidity or dilution flags suggests a stable short-term outlook.

    Key takeaways
    • Firefly Neuroscience Inc has a high price-to-book ratio of 5.09, indicating a premium valuation relative to its book value.
    • The company's return on equity and return on assets are negative, suggesting poor profitability and asset utilization.
    • Firefly Neuroscience Inc has no long-term debt and a debt-to-equity ratio of 0.0, indicating a conservative capital structure.
    • The company's operating and free cash flows are negative, indicating a significant cash outflow from operations.
    • The company's liquidity position is characterized by a current ratio of 1.43, suggesting it has sufficient short-term assets to cover its short-term liabilities.
    • Firefly Neuroscience Inc's revenue is concentrated in a single business segment, with no disclosed geographic diversification.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $1,29
    Market cap
    $38.8M
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    5.1x
    P / Tangible book
    5.1x
    Tangible book
    $7.6M
    Net cash
    Current ratio
    1.4
    Debt / equity
    0.0
    ROA
    -1.9%
    ROE
    -2.6%
    Cash conversion
    41.0%
    CapEx / revenue
    -11.2%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    INDUSTRYSEGMENTCOMPANYTechnologyIndustryIT Services473,3B node revenueACN 14,7%IBM 14,3%INGM 11,1%CRM 8,8%CTSH 4,5%ADP 4,3%INFY 4,1%LDOS 3,6%Other 34,7%
    Source: company disclosures · own-taxonomy revenue-covered setAIFF 0,0% · rank #92 of 104

    Business relationships

    Business relationships1 disclosed relationship · 1 type · extracted from filings & disclosures
    Partners1
    NOVARTIS AGNVS.OPartner95%Source ↗

    Supply chain

    Vendors → AIFF ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSAIFFAIFFFirefly Neuroscience Inc1 entityNOVARTIS AGUS
    1 mention in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-06-24

    Peer comparison

    Peer comparison8 peers · vs AIFF · multiples and returns
    AC
    ACN
    Accenture PLC
    $137,45
    86,9B USD
    P/E
    10,5x
    vs self
    Div yield
    4,3 %
    vs self
    ROE
    25,0 %
    +285,3 vs self
    IB
    IBM
    Intl Business Machines Corp
    $39,71
    347,6B USD
    P/E
    180,7x
    vs self
    Div yield
    2,9 %
    vs self
    ROE
    7,6 %
    +268,0 vs self
    IN
    INGM
    INGRAM MICRO INC.
    $28,45
    6,6B USD
    P/E
    17,8x
    vs self
    Div yield
    1,2 %
    vs self
    ROE
    7,7 %
    +268,1 vs self
    CR
    CRM
    Salesforce Inc
    $166,64
    145,1B USD
    P/E
    62,1x
    vs self
    Div yield
    vs self
    ROE
    6,2 %
    +266,5 vs self
    CT
    CTSH
    Cognizant Tech Solutions
    $41,44
    19,6B USD
    P/E
    44,3x
    vs self
    Div yield
    2,5 %
    vs self
    ROE
    4,1 %
    +264,4 vs self
    AD
    ADP
    Automatic Data Processing, Inc.
    $239,51
    95,9B USD
    P/E
    102,5x
    vs self
    Div yield
    3,2 %
    vs self
    ROE
    18,2 %
    +278,6 vs self
    IN
    INFY
    Infosys Ltd
    $11,90
    48,2B USD
    P/E
    0,7x
    vs self
    Div yield
    4,2 %
    vs self
    ROE
    7,7 %
    +268,0 vs self
    LD
    LDOS
    LEIDOS, INC.
    $121,69
    15,3B USD
    P/E
    10,7x
    vs self
    Div yield
    1,2 %
    vs self
    ROE
    29,4 %
    +289,8 vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin-894,0 %Bottom quartile
    Net Margin-1 741,0 %Bottom quartile
    ROE-260,3 %Bottom quartile
    Capex / Rev-11,2 %Bottom quartile
    D/E0,00Above P75
    Cash Conv0,41Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 172 416 sh3 grants3 insiders
    • Menawat Arun SwarupDirector · Deferred Stock Units → Common StockAcquired 73 892grant · 2025-10-28
    • POSNER BRIAN MDirector · Deferred Stock Units → Common StockAcquired 49 262grant · 2025-10-28
    • Vnook StellaDirector · Deferred Stock Units → Common StockAcquired 49 262grant · 2025-10-28

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Capex To Revenue
      capital_expenditure / revenue
    Source documents
    • Firefly Neuroscience Inc Market data — financials · 2026-05-27

    Ownership & reference

    Top holders

    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$0M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$0M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$0M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Leadership

    • Jamie BenoitChairman of the Board, Chief Executive Officer
    • Stanley Arthur ReesePresident, Director

    Insider activity

    Net selling0 buys · 10 sellsnet -$1,0M3 insiders · last 365d
    • DeCaprio DavidDirector, President and COO · Common StockOther 44 872 · 2026-03-10
    • Lipschitz GregoryDirector, Chief Executive Officer · Common StockOther 65 988 · 2026-03-10
    • Windsor Private Capital LP10% owner · Common StockSold 78 031 @ $2,07$162K · 2025-10-22
    • Windsor Private Capital LP10% owner · Common StockSold 19 222 @ $2,40$46K · 2025-10-21
    • Windsor Private Capital LP10% owner · Common StockSold 33 500 @ $2,46$82K · 2025-10-20
    • Windsor Private Capital LP10% owner · Common StockSold 45 036 @ $2,55$115K · 2025-10-17
    • Windsor Private Capital LP10% owner · Common StockSold 40 139 @ $2,65$106K · 2025-10-16
    • Windsor Private Capital LP10% owner · Common StockSold 17 500 @ $2,74$48K · 2025-10-15
    • Windsor Private Capital LP10% owner · Common StockSold 29 500 @ $2,74$81K · 2025-10-14
    • Windsor Private Capital LP10% owner · Common StockSold 32 136 @ $2,65$85K · 2025-10-13
    • Windsor Private Capital LP10% owner · Common StockSold 74 810 @ $2,70$202K · 2025-10-10
    • Windsor Private Capital LP10% owner · Common StockSold 30 126 @ $2,94$89K · 2025-10-09

    Short positioning

    747.6Kshares short+1.2% vs prior
    1.63days to cover
    33.5%short of daily vol
    355fails-to-deliver
    as of 2026-06-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    AIFF.OCanonical
    NASDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.
    Relationship graph
    AIFFNVS.OIT Services &
    This companySectorPartners

    Evidence & claims

    From filings & derived data
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 127.7%Derived (calculated)
    • Net margin (FY 2025-12-31): -1,741.0%Derived (calculated)
    • Gross margin (FY 2025-12-31): 56.5%Derived (calculated)
    • Return on equity (FY 2025-12-31): -260.3%Derived (calculated)
    • Return on assets (FY 2025-12-31): -189.8%Derived (calculated)
    • Current ratio (FY 2025-12-31): 1.43xDerived (calculated)
    • Debt-to-equity (FY 2025-12-31): 0.37xDerived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2023-12-31): 302.8%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -23.1%Derived (calculated)
    • Gross profit (YoY) (2025-12-31 vs 2024-12-31): 497.2%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): -90.1%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -33.1%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): 11.9%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 2,136.5%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -42.9%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 957.4%Derived (calculated)
    • R&D expense (YoY) (2025-12-31 vs 2024-12-31): -24.2%Derived (calculated)
    • Current assets (annual): USD 4.03MSEC XBRL filing
    • Total liabilities (annual): USD 2.84MSEC XBRL filing
    • Pre-tax income (annual): USD -19.88MSEC XBRL filing
    • Operating income (annual): USD -8.86MSEC XBRL filing
    • Shares outstanding (annual): 13.96MSEC XBRL filing
    • Gross profit (annual): USD 645KSEC XBRL filing
    • Revenue (annual): USD 1.14MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-07-28EVENTUpcomingQ2 2026 earnings (expected) estimated date
    2026-05-13FILINGFORM 10-Q →
    2026-05-12FILINGCURRENT REPORT →
    2026-04-22FILINGCURRENT REPORT →
    2026-03-31FILINGFORM 10-K →
    2026-03-12FILINGCURRENT REPORT →
    2026-03-10 00:00 UTCINSIDER2 insider transactions — 2026-03
    2026-03-10INSIDERDeCaprio David transacted 44.9k sh — Director, President and COO
    2026-03-10INSIDERLipschitz Gregory transacted 66.0k sh — Director, Chief Executive Officer
    2026-02-04FILINGCURRENT REPORT →
    2025-12-19FILINGCURRENT REPORT →
    2025-11-12FILINGQUARTERLY REPORT →
    2025-10-31FILINGCURRENT REPORT →
    2025-10-28 00:00 UTCINSIDER13 insider transactions — 2025-10 · net sell $1.0M 3 derivative
    2025-10-28INSIDERMenawat Arun Swarup acquired 73.9k sh Deferred Stock Units — Director
    2025-10-28INSIDERPOSNER BRIAN M acquired 49.3k sh Deferred Stock Units — Director
    2025-10-28INSIDERVnook Stella acquired 49.3k sh Deferred Stock Units — Director
    2025-10-22INSIDERWindsor Private Capital LP sold 78.0k sh — 10% owner ~$162k
    2025-10-21INSIDERWindsor Private Capital LP sold 19.2k sh — 10% owner ~$46k
    2025-10-20INSIDERWindsor Private Capital LP sold 33.5k sh — 10% owner ~$82k
    2025-10-17INSIDERWindsor Private Capital LP sold 45.0k sh — 10% owner ~$115k
    2025-10-16INSIDERWindsor Private Capital LP sold 40.1k sh — 10% owner ~$106k
    2025-10-15INSIDERWindsor Private Capital LP sold 17.5k sh — 10% owner ~$48k
    2025-10-14INSIDERWindsor Private Capital LP sold 29.5k sh — 10% owner ~$81k
    2025-10-13INSIDERWindsor Private Capital LP sold 32.1k sh — 10% owner ~$85k
    2025-10-10INSIDERWindsor Private Capital LP sold 74.8k sh — 10% owner ~$202k
    2025-10-09INSIDERWindsor Private Capital LP sold 30.1k sh — 10% owner ~$89k
    2025-10-03FILINGDEF 14A filing →
    2025-09-05FILINGCURRENT REPORT →
    2025-05-19 00:00 UTCINSIDER1 insider transaction — 2025-05 1 derivative
    2025-04-18 00:00 UTCINSIDER2 insider transactions — 2025-04 2 derivative
    2025-03-10 00:00 UTCINSIDER6 insider transactions — 2025-03 6 derivative
    2024-10-22 00:00 UTCINSIDER1 insider transaction — 2024-10
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-07-07 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage